Who is sponsoring NCT03854279?

NCT03854279 is sponsored by Oslo University Hospital.

What drugs are being tested in NCT03854279?

Interventions in NCT03854279: tonsillar dissection.

What condition does NCT03854279 study?

NCT03854279 studies Tonsillar Hypertrophy, Tonsillitis.

Is NCT03854279 still recruiting?

NCT03854279 is currently status unknown. Last updated 26 February 2019.

Last reviewed 2019-02-26 · How we verify

NCT03854279

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Bizact With Electroscissor for Tonsillectomy

Status unknown Phase 4 Last updated 26 February 2019

What this trial tests

Phase 4 trial testing tonsillar dissection in Tonsillar Hypertrophy, Tonsillitis in 60 participants. Status unknown.

Timeline

20 February 2019

Primary endpoint
31 October 2019

31 December 2020

Quick facts

Lead sponsor	Oslo University Hospital
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	20 February 2019
Primary completion	31 October 2019
Estimated completion	31 December 2020
Sites	1 location across Norway

Drugs / interventions tested

tonsillar dissection

Conditions studied

Tonsillar Hypertrophy, Tonsillitis — all drugs for Tonsillar Hypertrophy, Tonsillitis →

Sponsor

Oslo University Hospital

Who can join

Adults 16 to 40, any sex, with Tonsillar Hypertrophy, Tonsillitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In a randomized, partly double-blind prospective setup we want to compare traditional adult electro-scissor tonsillectomy With ultrasound Technology, Bizact.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Oslo University Hospital trials

Trials by the same sponsor.

NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03854279 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
Last refreshed: 26 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03854279.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing